Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | BACE1 | P56817 | 6/20 | 0.33 |
| ▸ | MAP4K4 | O95819 | 5/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.32 |
| ▸ | AXL | P30530 | 1/20 | 0.32 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.32 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.32 |
| ▸ | PRKCA | P17252 | 1/20 | 0.32 |
| ▸ | GSK3B | P49841 | 1/20 | 0.32 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.32 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2171684 | 0.84 | BACE1 (0.43) | BACE1 | |
| SCHEMBL2173280 | 0.84 | PGR (0.40) | BACE1NPY5R | |
| SCHEMBL8412303 | 0.84 | HSD17B2 (0.38) | — | |
| SCHEMBL2175983 | 0.83 | BACE1 (0.38) | BACE1 | |
| SCHEMBL2175281 | 0.82 | BACE1 (0.45) | BACE1BRD4 | |
| SCHEMBL14643302 | 0.81 | — | — | |
| SCHEMBL2171800 | 0.81 | BACE1 (0.47) | BACE1MEN1PSIP1AXLMKNK1 | |
| SCHEMBL13663905 | 0.80 | BACE1 (0.33) | BACE1GSK3B | |
| SCHEMBL13663904 | 0.80 | HTR7 (0.38) | BACE1 | |
| SCHEMBL2174928 | 0.79 | PGR (0.38) | BACE1BRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006065277-A2 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS | SCHERING CORPORATION (US) | 2006-06-22 | — | — | WO | disclosed |